4.4 Review

Schnitzler's syndrome: lessons from 281 cases

Journal

CLINICAL AND TRANSLATIONAL ALLERGY
Volume 4, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/2045-7022-4-41

Keywords

Schnitzler's syndrome; Interleukin-1 beta; Autoinflammation; Chronic urticaria; Paraprotein; Monoclonal gammopathy

Categories

Funding

  1. Novartis
  2. SOBI

Ask authors/readers for more resources

Schnitzler's syndrome is an autoinflammatory disorder characterized by the association of a monoclonal IgM (or IgG) gammopathy, a chronic urticarial rash, and signs and symptoms of systemic inflammation, including fever, arthralgias and bone pain. It was first described in 1972. This review summarizes the clinical features, efficacy of therapies, and follow-up data of the 281 cases that have been reported to date. Also, the results of skin histology, bone imaging, laboratory investigations, and studies of the pathogenesis will be discussed, including the pivotal role of interleukin-1 beta in this disorder.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available